Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

Merck & Co shares were down about 0.3% at $108.59 in afternoon trade on Wednesday after the drugmaker said it had completed its cash tender offer for Cidara Therapeutics and expected to finish the acquisition through a merger later in the day. The company said the deal will be treated as an asset acquisition, lifting 2026 research and development expense by about $9.0 billion and cutting earnings per share by roughly 30 cents in the first 12 months. “The acquisition of Cidara strengthens and complements our expanding respiratory portfolio,” Chief Executive Robert M. Davis said. Merck.com
Pentagon-Lockheed deal aims to triple PAC-3 Patriot interceptor output to 2,000 a year

Pentagon-Lockheed deal aims to triple PAC-3 Patriot interceptor output to 2,000 a year

The U.S. Department of War said it has signed a seven-year framework agreement with Lockheed Martin to lift annual production of the PAC-3 Missile Segment Enhancement — a Patriot interceptor meant to hit incoming missiles — to about 2,000 units from roughly 600. The department said it will also work with key suppliers on seven-year subcontracts, part of what it calls a new acquisition model. Michael Duffey, the under secretary for acquisition and sustainment, called it “a fundamental shift in how we rapidly expand munitions production.” U.S. Department of War
7 January 2026
1 559 560 561 562 563 893
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.